QNTM
NASDAQ
$3.04
FSD Pharma Inc - Class B - Class B (Sub Voting) (QNTM)
Quantum BioPharma Ltd. (QNTM) is an innovative biotechnology company focused on advancing transformative therapies for oncology and autoimmune diseases. With a robust pipeline of biopharmaceutical products, QNTM is committed to utilizing cutting-edge research and development to address critical unmet medical needs in these therapeutic areas. The company's strategic partnerships and experienced leadership position it to successfully navigate the complexities of the biopharmaceutical landscape. As the demand for groundbreaking therapeutics rises, Quantum BioPharma presents a strong investment opportunity for institutional investors seeking exposure to the dynamic healthcare sector.
Sector:
Healthcare
Industry:
Biotechnology
Target: $12.45 (+309.54%)
Market Cap
$18M
Free Cash Flow Yield
-32.02%
Beta (5Y)
1.54
Price Chart
Valuation
Market Cap$18M
P/S91.86
P/B42.03
Profitability
EBITDA-$31M
EPS-$8.22
Financial Health
Debt-to-Equity146.2%
Free Cash Flow Yield-32.02%
Growth & Risk
FCF 5Y CAGR-20.20%
Beta (5Y)1.54
Sharpe Ratio-0.71